Tofogliflozin and Pemafibrate Combination Therapy Prevents Nonalcoholic Steatohepatitis (NASH) Development of Novel Metabolic Syndrome-Related NASH Model Mice

被引：0
|
作者：
Sasaki, Yusuke
Asahiyama, Masato
Kamiya, Wakana
Sakai, Juro
Kodama, Tatsuhiko
Tanaka, Toshiya
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1153-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
    Takayama, Fusako
    Egashira, Toru
    Kawasaki, Hiromu
    Mankura, Mitsumasa
    Nakamoto, Kazuo
    Okada, Shigeru
    Mori, Akitane
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2009, 45 (03) : 335 - 340
  • [2] Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome
    Yener, Oktay
    Aksoy, Fikret
    Demir, Mustafa
    Ozcelik, Alp
    Erengul, Canan
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (04): : 411 - 415
  • [3] Nonalcoholic steatohepatitis (NASH) in adults with features of metabolic syndrome (MS)
    Aguilar-Urbano, Victor
    Pereda, Teresa
    Gonzalo-Marin, Juana
    Moreno-Mejias, Pedro
    Bercedo, Julio
    Verdugo, Jose
    Moya-Donoso, Francisco
    Fernandez-Cano, Francisco
    Rivas-Ruiz, Francisco
    Gandara-Adan, Norberto
    Navarro, J. M.
    [J]. HEPATOLOGY, 2013, 58 : 504A - 504A
  • [4] Antioxidant vitamin E prevents the development of nonalcoholic steatohepatitis (NASH) in rats
    Mattos, AA
    Zamin, IJ
    Mattos, AZ
    Coral, GP
    Santos, DE
    Soares, EB
    Migon, EZ
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 : 174 - 174
  • [5] Combining Genetic and Dietary Factors in Creation of a Novel Model of Nonalcoholic Steatohepatitis (NASH) in Mice
    Nelson, James E.
    Maliken, Bryan D.
    Dhillon, Barjinderjit K.
    Yeh, Matthew
    Beauchamp, M.
    Kowdley, Kris V.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S801 - S801
  • [6] GLYMPSE LIVER TEST FOR NONINVASIVE MONITORING OF COMBINATION DRUG THERAPY IN A RAT MODEL OF NONALCOHOLIC STEATOHEPATITIS (NASH)
    Cazanave, Sophie
    Pacula, Maciej
    Zagorska, Anna
    Warren, Andrew
    Sherman, Sarah
    Huang, Eric K.
    Walker, Katie
    Liu, Kathy
    Lopez, David
    Newstrom, David
    Zaboli, Shiva
    Bates, Jamie
    Liles, John
    Budas, Grant
    Breckenridge, David
    Billin, Andrew
    Kwong, Gabriel
    [J]. HEPATOLOGY, 2019, 70 : 1028A - 1029A
  • [7] A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
    Zobair M. Younossi
    Mohammed Jarrar
    Clare Nugent
    Manpreet Randhawa
    Mariam Afendy
    Maria Stepanova
    Nila Rafiq
    Zachary Goodman
    Vikas Chandhoke
    Ancha Baranova
    [J]. Obesity Surgery, 2008, 18 : 1430 - 1437
  • [8] A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
    Younossi, Zobair M.
    Jarrar, Mohammed
    Nugent, Clare
    Randhawa, Manpreet
    Afendy, Mariam
    Stepanova, Maria
    Rafiq, Nila
    Goodman, Zachary
    Chandhoke, Vikas
    Baranova, Ancha
    [J]. OBESITY SURGERY, 2008, 18 (11) : 1430 - 1437
  • [9] Combination of SGLT2 Inhibitor and Novel Selective PPARα Modulator, Tofogliflozin (Tofo) and Pemafibrate (Pema), Improves Survival Rate in STAM Mice as a Diabetic NASH Model
    Yano, Wataru
    Takizawa, Toshiaki
    Sasaki, Yusuke
    Asahiyama, Masato
    Kamiya, Wakana
    Nakagawa, Takashi
    Yamazaki, Hiroyuki
    Inoue, Keisuke
    Mizuno, Ken
    Sakai, Juro
    Kodama, Tatsuhiko
    Tanaka, Toshiya
    [J]. DIABETES, 2018, 67
  • [10] Steatosis and hepatic injury are attenuated by WY 14,643 in a metabolic syndrome-related model of NASH
    Larter, C. Z.
    Yeh, M. M.
    Van Rooyen, D. M.
    Brooling, J.
    Teoh, N. C.
    Farrell, G. C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A300 - A300
12345